Drug Repositioning: An Opportunity to Develop Novel Treatments for Alzheimer’s Disease
Wolfson Centre for Age-Related Diseases, Guy's Campus, King's College London, London SE1 1UL, UK
*
Author to whom correspondence should be addressed.
Pharmaceuticals 2013, 6(10), 1304-1321; https://doi.org/10.3390/ph6101304
Received: 17 September 2013 / Revised: 6 October 2013 / Accepted: 8 October 2013 / Published: 11 October 2013
(This article belongs to the Special Issue Drug Repositioning)
Alzheimer’s Disease (AD) is the most common cause of dementia, affecting approximately two thirds of the 35 million people worldwide with the condition. Despite this, effective treatments are lacking, and there are no drugs that elicit disease modifying effects to improve outcome. There is an urgent need to develop and evaluate more effective pharmacological treatments. Drug repositioning offers an exciting opportunity to repurpose existing licensed treatments for use in AD, with the benefit of providing a far more rapid route to the clinic than through novel drug discovery approaches. This review outlines the current most promising candidates for repositioning in AD, their supporting evidence and their progress through trials to date. Furthermore, it begins to explore the potential of new transcriptomic and microarray techniques to consider the future of drug repositioning as a viable approach to drug discovery.
View Full-Text
Keywords:
Alzheimer’s; repositioning; treatment; drug
This is an open access article distributed under the Creative Commons Attribution License
MDPI and ACS Style
Corbett, A.; Williams, G.; Ballard, C. Drug Repositioning: An Opportunity to Develop Novel Treatments for Alzheimer’s Disease. Pharmaceuticals 2013, 6, 1304-1321. https://doi.org/10.3390/ph6101304
AMA Style
Corbett A, Williams G, Ballard C. Drug Repositioning: An Opportunity to Develop Novel Treatments for Alzheimer’s Disease. Pharmaceuticals. 2013; 6(10):1304-1321. https://doi.org/10.3390/ph6101304
Chicago/Turabian StyleCorbett, Anne; Williams, Gareth; Ballard, Clive. 2013. "Drug Repositioning: An Opportunity to Develop Novel Treatments for Alzheimer’s Disease" Pharmaceuticals 6, no. 10: 1304-1321. https://doi.org/10.3390/ph6101304
Find Other Styles
Search more from Scilit